Systemic aspects of chronic rhinosinusitis

Immunology and Allergy Clinics of North America

Volumn 24, Issue 1, 2004, Pages 87-102

  Denburg, Judah A ^a   Keith, Paul K ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; INTERLEUKIN 5; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ALLERGY; ANTIGEN SPECIFICITY; ASTHMA; BONE MARROW; CELL DIFFERENTIATION; CHRONIC RHINITIS; HEMATOPOIESIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOTHERAPY; INFLAMMATION; INFLAMMATORY CELL; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RHINOSINUSITIS; STEM CELL;

EID: 1142285359     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(03)00106-1     Document Type: Review

References (92)

1. Togias A.G. Systemic immunologic and inflammatory aspects of allergic rhinitis. J Allergy Clin Immunol. 106:2000;S247-S250.
2. Beck L.A., Leung D.Y. Allergen sensitization through the skin induces systemic allergic responses. J Allergy Clin Immunol. 106:2000;S258-S263.
3. Undem B.J., Kajekar R., Hunter D.D., Myers A.C. Neural integration and allergic disease. J Allergy Clin Immunol. 106:2000;S213-S220.
4. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 351:1998;1225-1232.
5. Leynaert B., Neukirch F., Demoly P., Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol. 106:2000;S201-S205.
6. Inman M.D. Bone marrow events in animal models of allergic inflammation and hyperresponsiveness. J Allergy Clin Immunol. 106:2000;S235-S241.
7. Denburg J.A., Sehmi R., Saito H., Jeong P.-S., Inman M.D., O'Byrne P.M. Systemic aspects of allergic inflammatory disease: bone marrow responses. J Allergy Clin Immunol. 106:2000;S242-S246.
8. Palframan R.T., Collins P.D., Williams T.J., Rankin S.M. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood. 91:1998;2240-2248.
9. Gibson P.G., Dolovich J., Girgis-Gabardo A., Morris M.M., Anderson M., Hargreave F.E.et al. The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils and their progenitors. Clin Exp Allergy. 20:1990;661-668.
10. Gibson P.G., Manning P.J., O'Byrne P.M., Girgis-Gabardo A., Dolovich J., Denburg J.A.et al. Allergen-induced asthmatic responses: relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors. Am Rev Respir Dis. 143:1991;331-335.
11. Gauvreau G.M., Watson R.M., O'Byrne P.M. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. Am J Respir Crit Care Med. 160:1999;640-647.
12. Newman L.J., Platts-Mills T.A., Phillips C.D., Hazen K.C., Gross C.W. Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia. JAMA. 271:1994;363-367.
13. Denburg J.A., Telizyn S., Belda A., Dolovich J., Bienenstock J. Increased numbers of circulating basophil progenitors in atopic patients. J Allergy Clin Immunol. 76:1985;466-472.
14. Denburg J.A., Dolovich J., Harnish D. Basophil mast cell and eosinophil growth and differentiation factors in human allergic disease. Clin Exp Allergy. 19:1989;249-254.
15. Denburg J.A., Inman M.D., Leber B., Sehmi R., O'Byrne P.M. The role of the bone marrow in allergy and asthma. Allergy. 51:1996;141-148.
16. Denburg J.A., Woolley M., Leber B., Linden M., O'Byrne P. Basophil and eosinophil differentiation in allergic reactions. J Allergy Clin Immunol. 94:1994;1135-1141.
17. Otsuka H., Dolovich J., Befus A.D., Bienenstock J., Denburg J.A. Peripheral blood basophils, basophil progenitors, and nasal metachromatic cells in allergic rhinitis. Am Rev Respir Dis. 133:1986;757-762.
18. Otsuka H., Dolovich J., Befus A.D., Telizyn S., Bienenstock J., Denburg J.A. Basophilic cell progenitors, nasal metachromatic cells, and peripheral blood basophils in ragweed-allergic patients. J Allergy Clin Immunol. 78:1986;365-371.
19. Otsuka H., Dolovich J., Richardson M., Bienenstock J., Denburg J.A. Metachromatic cell progenitors and specific growth and differentiation factors in human nasal mucosa and polyps. Am Rev Respir Dis. 136:1987;710-717.
20. Linden M., Svensson C., Andersson M., Greiff L., Andersson E., Denburg J.A.et al. Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis. Allergy. 54:1999;212-219.
21. Gibson P.G., Wong B.J., Hepperle M.J., Kline P.A., Girgis-Gabardo A., Guyatt G.et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy. 22:1992;525-532.
22. Denburg J.A., Davison M., Bienenstock J. Basophil production: stimulation by factors derived from guinea pig splenic T-lymphocytes. J Clin Invest. 65:1980;390-399.
23. + cells from asthmatic subjects: a novel marker of progenitor cell commitment toward eosinophilic differentiation. J Clin Invest. 100:1997;2466-2475.
24. Gauvreau G.M., O'Byrne P.M., Moqbel R., Velazquez J., Watson R.M., Howie K.J.et al. Enhanced expression of GM-CSF in differentiating eosinophils of atopic and atopic asthmatic subjects. Am J Respir Cell Mol Biol. 19:1998;55-62.
25. Humbert M., Corrigan C.J., Kimmitt P., Till S.J., Kay A.B., Durham S.R. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med. 156:1997;704-708.
26. van der Veen M.J., Van Neerven R.J., De Jong E.C., Aalberse R.C., Jansen H.M., van der Zee J.S. The late asthmatic response is associated with baseline allergen-specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin-5. Clin Exp Allergy. 29:1999;217-227.
27. Shi H.Z., Xiao C.Q., Zhong D., Qin S.M., Liu Y., Liang G.R.et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med. 157:1998;204-209.
28. Cameron L., Christodoulopoulos P., Lavigne F., Nakamura Y., Eidelman D., McEuen A.et al. Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor. J Immunol. 164:2000;1538-1545.
29. Civin C.I., Trischman T., Fackler M.J., Bernstein I., Buhring H., Campos L.et al. Leukocyte typing. Knapp W. Leukocyte typing IV. 1989;818-825 Oxford University Press, Oxford.
30. Sutherland D.R., Keating A. The CD34 antigen: structure, biology, and potential clinical applications. J Hematother. 1:1992;115-129.
31. + hemopoietic progenitor cells in atopic subjects. Am J Respir Cell Mol Biol. 15:1996;645-654.
32. + cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors. Am J Respir Cell Mol Biol. 20:1999;9-13.
33. Ohnishi M., Ruhno J., Bienenstock J., Dolovich J., Denburg J.A. Hematopoietic growth factor production by cultured cells of human nasal polyp epithelial scrapings: kinetics, cell source, and relationship to clinical status. J Allergy Clin Immunol. 83:1989;1091-1100.
34. Ohnishi M., Ruhno J., Bienenstock J., Milner R., Dolovich J., Denburg J.A. Human nasal polyp epithelial basophil/mast cell and eosinophil colony-stimulating activity: the effect is T-cell-dependent. Am Rev Respir Dis. 138:1988;560-564.
35. Ohnishi M., Ruhno J., Dolovich J., Denburg J.A. Allergic rhinitis nasal mucosal conditioned medium stimulates growth and differentiation of basophil/mast cell and eosinophil progenitors from atopic blood. J Allergy Clin Immunol. 81:1988;1149-1154.
36. Denburg J.A., Dolovich J., Ohtoshi T., Cox G., Gauldie J., Jordana M. The microenvironmental differentiation hypothesis of airway inflammation. Am J Rhinol. 4:1990;29-32.
37. Cox G., Ohtoshi T., Vancheri C., Denburg J.A., Dolovich J., Gauldie J.et al. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol. 4:1991;525-531.
38. Vancheri C., Gauldie J., Bienenstock J., Cox G., Scicchitano R., Stanisz A.et al. Human lung fibroblast-derived granulocyte-macrophage colony stimulating factor (GM-CSF) mediates eosinophil survival in vitro. Am J Respir Cell Mol Biol. 1:1989;289-295.
39. Vancheri C., Ohtoshi T., Cox G., Xaubet A., Abrams J.S., Gauldie J.et al. Neutrophilic differentiation induced by human upper airway fibroblast-derived granulocyte/macrophage colony-stimulating factor (GM-CSF). Am J Respir Cell Mol Biol. 4:1991;11-17.
40. Kim Y.K., Uno M., Hamilos D.L., Beck L., Bochner B., Schleimer R.et al. Immunolocalization of CD34 in nasal polyposis: effect of topical corticosteroids. Am J Respir Cell Mol Biol. 20:1999;388-397.
41. Rottem M., Barbieri S., Kinet J.P., Metcalfe D.D. Kinetics of the appearance of Fc epsilon RI-bearing cells in interleukin-3-dependent mouse bone marrow cultures: correlation with histamine content and mast cell maturation. Blood. 79:1992;972-980.
42. Rottem M., Hull G., Metcalfe D.D. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells. Exp Hematol. 22:1994;1147-1155.
43. Figueroa D.J., Breyer R.M., Defoe S.K., Kargman S., Daugherty B.L., Waldburger K.et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med. 163:2001;226-233.
44. Sehmi R., Dorman S., Baatjes A., Watson R., Foley R., Ying S.et al. Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation. Immunology. 109:2003;536-546.
45. Kung T.T., Stelts D.M., Zurcher J.A., Adams G.K. 3rd, Egan R.W., Kreutner W.et al. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol. 13:1995;360-365.
46. Fahy J.V., Fleming H.E., Wong H.H., Liu J.T., Su J.Q., Reimann J.et al. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med. 155:1997;1828-1834.
47. Minshall E.M., Schleimer R., Cameron L., Minnicozzi M., Egan R.W., Gutierrez-Ramos J.C.et al. Interleukin-5 expression in the bone marrow of sensitized Balb/c mice after allergen challenge. Am J Respir Crit Care Med. 158:1998;951-957.
48. Foster P.S., Hogan S.P., Ramsay A.J., Matthaei K.I., Young I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med. 183:1996;195-201.
49. Wang J., Palmer K., Lotvall J., Milan S., Lei X.F., Matthaei K.I.et al. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. J Clin Invest. 102:1998;1132-1141.
50. Saito H., Howie K., Wattie J., Denburg A., Ellis R., Inman M.D.et al. Allergen-induced murine upper airway inflammation: local and systemic changes in murine experimental allergic rhinitis. Immunology. 104:2001;226-234.
51. Saito H., Matsumoto K., Denburg A.E., Crawford L., Ellis R., Inman M.D. et al. Pathogenesis of murine experimental allergic rhinitis: a study of local and systemic consequences of IL-5 deficiency. J Immunol. 168:2002;3017-3023.
52. Gaspar Elsas M.I., Joseph D., Elsas P.X., Vargaftig B.B. Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge. Am J Respir Cell Mol Biol. 17:1997;404-413.
53. Ohkawara Y., Lei X.F., Stampfli M.R., Marshall J.S., Xing Z., Jordana M. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am J Respir Cell Mol Biol. 16:1997;510-520.
54. Wood L.J., Sehmi R., Dorman S., Hamid Q., Tulic M.K., Watson R.M.et al. Allergen-induced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma. Am J Respir Crit Care Med. 166:2002;883-889.
55. Agosti J.M., Sprenger J.D., Lum L.G., Witherspoon R.P., Fisher L.D., Storb R.et al. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med. 319:1988;1623-1628.
56. Hamelmann E., Oshiba A., Paluh J., Bradley K., Loader J., Potter T.A.et al. Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a murine model of airway sensitization. J Exp Med. 183:1996;1719-1729.
57. Hamelmann E., Oshiba A., Schwarze J., Bradley K., Loader J., Larsen G.L.et al. Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness. Am J Respir Cell Mol Biol. 16:1997;674-682.
58. Beeh K.M., Beier J., Kornmann O., Meier C., Taeumer T., Buhl R. A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5. Clin Exp Allergy. 33:2003;475-482.
59. Denburg J.A., Inman M.D., Sehmi R., Wood L.J., Gauvreau G.M., O'Byrne P.M. Extrapulmonary effects of inhaled corticosteroids. Schleimer R.P., O'Byrne P.M., Szefler S.et al. Inhaled steroids in asthma: optimizing effects in the airways. 2002;273-282 Marcel Dekker, New York.
60. Woolley M.J., Denburg J.A., Ellis R., Dahlback M., O'Byrne P.M. Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters. Am J Respir Cell Mol Biol. 11:1994;600-606.
61. Inman M.D., Denburg J.A., Ellis R., Dahlback M., O'Byrne P.M. Allergen-induced increase in bone marrow progenitors in airway hyperresponsive dogs: regulation by a serum hemopoietic factor. Am J Respir Cell Mol Biol. 15:1996;305-311.
62. 2 in vitro on allergen-induced increases in canine bone marrow progenitors. Am J Respir Cell Mol Biol. 17:1997;634-641.
63. Inman M.D., Sehmi R., O'Byrne P.M., Denburg J.A. The role of the bone marrow in allergic disease. Denburg J.A. Allergy and allergic diseases: the new mechanisms and therapeutics. 1998;85-102 Humana Press, Totowa (NJ).
64. Wood L.J., Inman M.D., Denburg J.A., O'Byrne P.M. Allergen challenge increases cell traffic between bone marrow and lung. Am J Respir Cell Mol Biol. 18:1998;759-767.
65. Gauvreau G.M., Wood L.J., Sehmi R., Watson R.M., Dorman S.C., Schleimer R.P.et al. The effects of inhaled budesonide on circulating eosinophil progenitors and their expression of cytokines after allergen challenge in subjects with atopic asthma. Am J Respir Crit Care Med. 162:2000;2139-2144.
66. + progenitors: relationship to GM-CSF expression and topical corticosteroids [abstract]. J Allergy Clin Immunol. 105:2000;S148.
67. Wood L.J., Sehmi R., Gauvreau G.M., Watson R.M., Foley R., Denburg J.A. et al. An inhaled corticosteroid, budesonide, reduces baseline but not allergen-induced increases in bone marrow inflammatory cell progenitors in asthmatic subjects. Am J Respir Crit Care Med. 159:1999;1457-1463.
68. Egan R.W., Athwahl D., Chou C.C., Chapman R.W., Emtage S., Jehn C.H.et al. Pulmonary biology of anti-interleukin 5 antibodies. Mem Inst Oswaldo Cruz. 92(suppl 2):1997;69-73.
69. Van Oosterhout A.J., Ladenius A.R., Savelkoul H.F., Van A.I., Delsman K.C., Nijkamp F.P. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis. 147:1993;548-552.
70. Karras J.G., McGraw K., McKay R.A., Cooper S.R., Lerner D., Lu T.et al. Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthma. J Immunol. 164:2000;5409-5415.
71. Leckie M.J., ten Brinke A., Khan J., Diamant Z., O'Connor B.J., Walls C.M.et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 356:2000;2144-2148.
72. Hogan S.P., Matthaei K.I., Young J.M., Koskinen A., Young I.G., Foster P.S. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol. 161:1998;1501-1509.
73. Mauser P.J., Pitman A., Witt A., Fernandez X., Zurcher J., Kung T.et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis. 148:1993;1623-1627.
74. Flood-Page P.T., Menzies-Gow A.N., Kay A.B., Robinson D.S. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med. 167:2003;199-204.
75. Menzies-Gow A., Flood-Page P., Sehmi R., Burman J., Hamid Q., Robinson D.S.et al. Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol. 111:2003;714-719.
76. Lindgren J.A., Stenke L., Mansour M., Edenius C., Lauren L., Nasman-Glaser B.et al. Formation and effects of leukotrienes and lipoxins in human bone marrow. J Lipid Mediat. 6:1993;313-320.
77. Bautz F., Denzlinger C., Kanz L., Mohle R. Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1. Blood. 97:2001;3433-3440.
78. Braccioni F., Dorman S.C., O'Byrne P.M., Inman M.D., Denburg J.A., Parameswaran K.et al. The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects. J Allergy Clin Immunol. 110:2002;96-101.
79. Higashi N., Taniguchi M., Mita H., Ishii T., Akiyama K. Nasal blockage and urinary leukotriene E4 concentration in patients with seasonal allergic rhinitis. Allergy. 58:2003;476-480.
80. Bryson J.M., Tasca R.A., Rowe-Jones J.M. Local and systemic eosinophilia in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis with and without polyposis. Clin Otolaryngol. 28:2003;55-58.
81. Reiss T.F., Chervinsky P., Dockhorn R.J., Shingo S., Seidenberg B., Edwards T.B. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med. 158:1998;1213-1220.
82. Pizzichini E., Leff J.A., Reiss T.F., Hendeles L., Boulet L.P., Wei L.X.et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J. 14:1999;12-18.
83. Philip G., Malmstrom K., Hampel F.C., Weinstein S.F., LaForce C.F., Ratner P.H.et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy. 32:2002;1020-1028.
84. Walker S.M., Pajno G.B., Lima M.T., Wilson D.R., Durham S.R. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol. 107:2001;87-93.
85. Bush R.K. The use of anti-IgE in the treatment of allergic asthma. Med Clin North Am. 86:2002;1113-1129.
86. Casale T.B., Condemi J., LaForce C., Nayak A., Rowe M., Watrous M.et al. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. JAMA. 286:2001;2956-2967.
87. Leung D.Y., Sampson H.A., Yunginger J.W., Schneider L.C., Wortel C.H., Davis F.M.et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med. 348:2003;986-993.
88. Simons F.E., Simons K.J. The pharmacology and use of H1-receptor- antagonist drugs. N Engl J Med. 330:1994;1663-1670.
89. Walsh G.M. The anti-inflammatory effects of cetirizine. Clin Exp Allergy. 24:1994;81-85.
90. Cyr M.M., Baatjes A.J., Hayes L.M., Crawford L., Denburg J.A. The effect of desloratadine on eosinophil/basophil progenitors and other inflammatory markers in seasonal allergic rhinitis: a placebo-controlled randomized study [abstract]. J Allergy Clin Immunol. 109:2002;S117.
91. Ozdemir R., Yorulmaz A., Kutlu R., Guven A., Aladag M., Sezgin A.et al. Loss of nocturnal decline of blood pressure in patients with nasal polyposis. Blood Press. 8:1999;165-171.
92. Kainulainen L., Nikoskelainen J., Ruuskanen O. Diagnostic findings in 95 Finnish patients with common variable immunodeficiency. J Clin Immunol. 21:2001;145-149.